The higher expression of CAFs in the tumor stroma at early disease stages in well- and moderately differentiated lesions involves a high sensitivity of FAPI, in a clinical setting usually characterized by low [18F]FDG intra-cell trapping due to enhanced glucose-6-phosphatase activity [39,67]. Here, G6PC1 is linked to neoplasm.